Will genetics really revolutionize the drug discovery process?

Current Opinion in Biotechnology

Volumn 8, Issue 6, 1997, Pages 669-674

  Gelbert, Lawrence M ^a   Gregg, Richard E ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDE; OLIGONUCLEOTIDE;

DRUG DEVELOPMENT; DRUG TARGETING; GENE SEQUENCE; GENETICS; GENOME; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; REVIEW;

EID: 0030707763     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(97)80117-6     Document Type: Article

References (63)

1. Lander ES. The new genomics: global views of biology. of oustanding interest Science. 274:1996;536-539 A comprehensive commentary on the future direction of genomics research. Fundamental changes in experimental paradigms and technology are described for the analysis of DNA, RNA and protein sequences. The affect of new genomic technologies on society are also discussed.
2. Collins FS. Positional cloning moves from perditional to traditional. Nat Genet. 9:1995;347-350.
3. XREF database at the National Center for Biotechnology Information on the World Wide Web URL: http://www.ncbi.nlm.nih.gov/XREFdb/m of special interest.
4. A comprehensive commentary on the future of genomics research. Fundamental changes in experimental paradigms and technology are described for the analysis of DNA, RNA and protein sequences. The affect of new genomic technologies on society are also discussed.
5. Cohen J. The genomics gamble. of special interest Science. 275:1997;767-772 A recent analysis of the impact of genomics in the pharmaceutical and biotechnology sectors.
6. Morell V. Life's last domain. Nature. 273:1996;1043-1045.
7. Bult CJ, White O, Olsen GJ, Zhou L, Fleischmann RD, Sutton GG, Blake JA, FitzGerald LM, Clayton RA, Gocayne JD, et al. Complete genome sequence of the methanogenic archaeon, Methanococcus jannaschii. Science. 273:1996;1058-1073.
8. Clayton RA, White O, Ketchum KA, Venter JC. The first genome from the third domain of life. of special interest Nature. 387:1997;459-462 Analysis of several sequenced genomes was performed to group genes from different organisms by function (orthologue analysis). The use of comparative genomics to identify gene function and biological pathways is highlighted.
9. Koonin EV. Big time for small genomes. Genome Res. 7:1997;418-421.
10. Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM, et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science. 269:1995;496-512.
11. Nowak R. Bacterial genome sequence bagged. Science. 269:1995;468-470.
12. Blattner FR, Plunkett G III, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, et al. The complete genome sequence of Escherichia coli K-12. Science. 277:1997;1453-1462.
13. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. of special interest Nature. 388:1997;539-547 The sequencing and analysis of the genome of a major pathogen is presented. Also see Dolittle 1997 [13] for a discussion of the impact of this paper.
14. Dolittle RF. A bug with excess gastric avidity. Nature. 388:1997;515-516.
15. Mewes HW, Albermann K, Bähr M, Frishman D, Gleissner A, Hani J, Heumann K, Kleine K, Maieri A, Oliver SG, et al. Overview of the yeast genome. of special interest Nature. 387:1997;7-8 A summary of the genes, and their potential function, identified from sequencing the yeast genome. This reference includes a comprehensive list of World Wide Web sites to access yeast genome data.
16. Multipurpose Automated Genome Project Investigation Environment (MAGPIE) on World Wide Web URL: http://www.mcs.anl.gov/home/gaasterl/magpie.html.
17. Entrez Genome Division at the National Center for Biotechnology Information (NCBI) on World Wide Web URL: http://www.ncbi.nlm.nih.gov/Entrez/Genome/org.html.
18. The Institute for Genomic Research (TIGR) Microbial database on World Wide Web URL: http://www.tigr.org/tdb/mdb/mdb.html.
19. Roberts L. Gambling on a shortcut to genome sequencing. Science. 252:1991;1618-1619.
20. Hillier LD, Lennon G, Becker M, Bonaldo MF, Chiapelli B, Chissoe S, Dietrich N, DuBuque T, Favello A, Gish W, et al. Generation and analysis of 280,000 human expressed sequence tags. Genome Res. 6:1996;807-828 The Washington University/Merck expressed sequenced tag (EST) database represents one of the largest public databases of EST sequences, and contains 319,311 EST sequences. A complete description of source of the cDNA clones, the generation of the EST sequences, and analysis of the data for 280,000 sequences from 22 different cDNA libraries (from 12 different tissues and three developmental states) is provided. Essential reading for scientists searching this EST database.
21. Unigene unique human gene sequence collection at the National Center for Biotechnology Information on World Wide Web URL: http://www.ncbi.nlm.nih.gov/UniGene/index.html.
22. Fannon MR. Gene expression in normal and disease states - identification of therapeutic targets. Trends Biotechnol. 14:1996;294-298.
23. Schuler GD, Boguski MS, Stewart EA, Stein LD, Gyapay G, Rice K, White RE, Rodriguez-Tome P, Aggarwal A, Bajorek E, et al. A gene map of the human genome. Science. 274:1996;540-546.
24. Gerhold D, Caskey CT. It's the genes! EST access to the human genome content. Bioessays. 18:1996;973-981.
25. Dayan AD. Transgenic rodents in toxicology. Int J Exp Path. 77:1996;251-256.
26. Polite HG. Transgenic model applications to drug discovery. Int J Exp Path. 77:1996;257-262.
27. Hieter P, Bassett DE Jr, Valle D. The yeast genoma - a common currency. Nat Genet. 13:1996;253-255.
28. Miklos GLG, Rubin GM. The role of the genome project in determining gene function: insights from model organisms. Cell. 86:1996;521-529.
29. Botstein D, Chervitz SA, Cherry JM. Yeast as a model organism. Science. 277:1997;1259-1260.
30. Goffeau A, Barrell BG, Bussy H, Davis RW, Dujon B, Feldman H, Galibert F, Hoheisel JD, Jacq C, Johnston M, et al. Life with 6000 genes. Science. 274:1996;546-567.
31. Shoemaker DD, Lashkari DA, Morris D, Mittmann M, Davis RW. Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy. Nat Genet. 14:1996;450-456.
32. Mushegian AR, Bassett DE Jr, Boguski MS, Bork P, Koonin EV. Positionally cloned human disease genes: patterns of evolutionary conservation and functional motifs. Proc Natl Acad Sci USA. 94:1997;5831-5836.
33. Vidal M, Brachmann RK, Fataey A, Harlow E, Boeke JD. Reverse two-hybrid and one-hybrid systems to detect dissociation of protein - protein and protein - DNA interactions. Proc Natl Acad Sci USA. 96:1996;10315-10320.
34. Rossi F, Charlton CA, Blau HM. Monitoring protein - protein interactions in intact eukaryotic cells by β-galactosidase complementation. Proc Natl Acad Sci USA. 94:1997;8405-8410.
35. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 332:1995;912-917.
36. Szabo CI, King MC. Population genetics of BRCA1 and BRCA2. Am J Hum Genet. 60:1997;1013-1020.
37. Ansari-Lari MA, Liu XM, Metzker ML, Rut AR, Gibbs RA. The extent of genetic variation in the CCR5 gene. of special interest Nat Genet. 16:1997;221-222 Summarizes recent data on genetic variation of the CCR5 chemokine receptor that the HIV virus uses to infect T-lymphocytes. A recent example of genetic variation that has major implications for HIV drug discovery.
38. Pease AC, Solas D, Sullivan EJ, Cronin MT, Holmes CP, Fodor SPA. Light-generated oligonucleotide arrays for rapid DNA sequence analysis. Proc Natl Acad Sci USA. 91:1994;5022-5026.
39. Lipshutz RJ, Morris D, Chee M, Hubbell E, Kozal MJ, Shen N, Yang R, Fodor SPA. Using oligonucleotide probe arrays to access genetic diversity. Biotechniques. 19:1995;442-447.
40. Chee M, Yang R, Hubbell E, Berno A, Huang XC, Stern D, Winkler J, Lockhart DJ, Morris MS, Fodor SPA. Accessing genetic information with high-density DNA arrays. of oustanding interest Science. 274:1996;610-614 An oligonucleotide resequencing array was designed to sequence the human mitochondrial genome, which is approximately 16.6 kb. Using this array it was possible to resequence with 99% accuracy. A scheme to hybridize two samples simultaneously for the identification of polymorphisms is described. The advantages of using oligonucleotide arrays for resequencing are also described.
41. Risch N, Merikangas K. The future of genetic studies of complex human diseases. of oustanding interest Science. 273:1996;1516-1517 The authors compare the two primary genetic approaches for identifying human disease genes, linkage analysis and association studies. Mathematical models are presented that compare the linkage and association studies and predict the number of families (or sib pairs) and genetic markers required to identify genes using each approach. The analysis presented by the authors highlight how single nucleotide polymorphisms and oligonucleotide array technology will facilitate the identification of human disease genes through association studies.
42. Kruglyak L. The use of a genetic map of biallelic markers in linkage studies. of special interest Nat Genet. 17:1997;21-24 Compares single nucleotide polymorphisms to more conventional genetic markers and the impact of single nucleotide polymorphism markers on future genetic studies.
43. Shuber AP, Michalowsky LA, Nass GS, Skoletsky J, Hire LM, Kotsopoulos SK, Phipps MF, Barberio DM, Klinger KW. High throughput parallel analysis of hundreds of patient samples for more than 100 mutations in multiple disease genes. Hum Mol Genet. 6:1997;337-347.
44. Smith J, Modrich P. Mutation detection with MutH, MutL, and MutS mismatch repair proteins. Proc Natl Acad Sci USA. 93:1996;4374-4379.
45. Nebert DW. Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist? of outstanding interest Am J Hum Genet. 60:1997;284-295 An excellent review of pharmacogenetics and the affect of genetic variation on drug metabolizing enzymes. Also see Puga 1997 [45] for additional information on genetic variation in drug metabolizing enzymes.
46. Puga A, Nebert DW, McKinnon RA, Menon AG. Genetic polymorphisms in human drug-metabolizing enzymes: potential uses of reverse genetics to identify genes of toxicological relevance. Crit Rev Toxicol. 27:1997;199-222.
47. Sachse C, Brockmoller J, Bauer S, Roots I. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. of outstanding interest Am J Hum Genet. 60:1997;265-271 One of the largest and most comprehensive pharmacogenetics studies published. This work highlights the large number of different types of genetic variants that are known to occur in drug metabolizing enzymes. This study is a good example of the complexity and technical challenges of future pharmacogenetic studies.
48. Meyer UA, Zanger UM. Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu Rev Pharmacol Toxicol. 37:1997;269-296.
49. Nakajima T, Elovaara E, Anttila S, Hirvonen A, Camus AM, Hayes JD, Ketterer B, Vainio H. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis. 16:1995;707-711.
50. Yengi L, Inskip A, Gilford J, Alldersea J, Bailey L, Smith A, Lear JT, Heagerty AH, Bowers B, Hand P, et al. Polymorphism at the glutathione S-transferase locus GSTM3: Interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res. 56:1996;1974-1977.
51. Blanchard AP, Hood L. Sequence to array: probing the genome's secrets. of special interest Nat Biotechnol. 14:1996;1649 A recent review of the application of array technology for DNA resequencing and for studying gene expression. How oligonucleotide arrays are synthesized and several applications are described, and a comparison of oligonucleotide and cDNA arrays is presented. Also see [51].
52. To affinity...and beyond (Editorial). Nat Genet. 14:1996;367-370.
53. Lockhart DJ, Dong H, Byrne MC, Follettie M, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL. Expression monitoring by hybridization to high-density oligonucleotide arrays. of outstanding interest Nat Biotechnol. 14:1996;1675-1680 The first published example of large-scale monitoring of gene expression using oligonucleotide arrays. A detailed description of the technology.
54. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA. 93:1996;10614-10619.
55. Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, Woolley DE, Davis RW. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA. 94:1997;2150-2155.
56. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA. Laser capture microdissection. of outstanding interest Science. 274:1996;998-1001 The microdissection procedure described allows for the purification of homogeneous cell populations from solid tissues, and will allow for the analysis of RNA expression in vivo.
57. Madej T, Boguski MS, Bryant SH. Threading analysis suggests that the obese gene product may be a helical cytokine. FEBS Lett. 373:1995;13-18.
58. Blundell TL. Structure-based drug design. of special interest Nature. 384:1996;23-26 A recent review of the impact of structural biology on drug design. Several examples of the application of three-dimensional structures to drug design are presented, as is the integration of structural-based approaches to the drug discovery processes. Also see Shuker 1996 [58].
59. Shuker SB, Hajduk PJ, Meadows RP, Fesik SW. Discovering high-affinity ligand for proteins: SAR by NMR. Science. 274:1996;1531-1534.
60. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace AJ Jr, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL. An information-intensive approach to the molecular pharmacology of cancer. of outstanding interest Science. 275:1997;343-349 This work highlights the application of bioinformatics and genetic analysis to compound screening and drug discovery.
61. Lyall A. Bioinformatics in the pharmaceutical industry. Trends Biotechnol. 14:1996;308-312.
62. Sánchez R, Sali A. Advances in comparative protein-structure modelling. Curr Opin Struct Biol. 7:1997;206-214.
63. Burke DT, Burns MA, Mastrangelo C. Microfabrication technologies for the integration of nucleic acid analysis. of special interest Genome Res. 7:1997;189-197 A comprehensive review of the application of microfabrication technologies to nucleic acid analysis. The compatibility of nucleic acids with microfabrication strategies and future applications are presented. A preview of the next generation of microfabrication applications to emerge after oligonucleotide and cDNA arrays.